EpiPen maker caves in to social media pressure, drops price by 50%
In a big win for people power, drugmaker Mylan has caved in to pressure across social media and announced it will create a generic version of the EpiPen. The cheaper version will be priced at ...
No comments yet. Be the first.
Advertising Perspectives LLC
Search Advertising Perspectives